[6-K] PAINREFORM LTD. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

PainReform Ltd. filed a Form 6-K reporting that on October 1, 2025 it issued a press release announcing its financial results for the six months ended June 30, 2025 and furnished unaudited condensed financial statements and an operating and financial review for that period.

The filing also discloses a board change: Professor Eli Hazum resigned effective September 30, 2025 for personal reasons, expressly not due to any disagreement with management, and Asaf Shavit was appointed to the Board effective immediately; Mr. Shavit is a Certified Public Accountant with 35+ years of audit, tax and financial advisory experience.

Positive

• Unaudited condensed financial statements and an operating and financial review for the six months ended June 30, 2025 were published, increasing transparency
• Experienced board appointment: Asaf Shavit brings 35+ years in audit, tax and financial advisory and is a Certified Public Accountant

Negative

• Resignation of a board member: Professor Eli Hazum resigned effective September 30, 2025, reducing board continuity
• Financial statements are unaudited, meaning the interim results are preliminary and not audited within this filing text

Insights

Financial Analyst

TL;DR: Company provided interim financials and an operating review; no audited results included and no indication of disagreement on board change.

The filing confirms the company published unaudited condensed financial statements for the six months ended June 30, 2025 and an accompanying operating and financial review, which are material for assessing recent performance but remain unaudited and therefore preliminary. The disclosure meets routine investor transparency expectations for a foreign private issuer. There is no additional financial data in this filing text to evaluate trends, margins or cash position; investors must review the attached exhibits for numeric details.

Corporate Governance Expert

TL;DR: Board turnover occurred with an independent-seeming resignation and an immediate appointment of an experienced audit professional.

The resignation of Professor Eli Hazum is explicitly stated to be for personal reasons and not due to disagreement with management, which reduces immediate governance risk. The appointment of Asaf Shavit, a long-tenured audit and advisory partner and CPA, strengthens financial oversight capabilities on the Board given his expertise in audits, M&A and cross-border transactions. Documentation does not indicate committee assignments or independence classifications; those details should be confirmed in the company’s proxy or subsequent filings.

0001801834false--12-31Q2

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16
 of the Securities Exchange Act of 1934

For the month of October 2025

Commission File Number: 001-39481

PainReform Ltd.
 (Translation of registrant’s name into English)

65 Yigal Alon St., Tel Aviv 6744316
 Israel
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

This Form 6-K, excluding the press release attached hereto as Exhibit 99.3, is incorporated by reference into the Company’s Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and the Company’s Registration Statements on Form F-3 (Registration No. 333-282264, 333-254982, 333-276485, 333-277594, 333-283655 and 333-286941), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. .

On October 1, 2025, PainReform Ltd. (the “Company”) issued a press release announcing its financial results for the six months ended June 30, 2025. The Company is also publishing its unaudited condensed financial statements, as well as its operating and financial review as of June 30, 2025 and for the six months then ended. Attached hereto are the following exhibits.

99.1	Unaudited Condensed Financial Statements as of June 30, 2025
99.2	Operating and Financial Review as of June 30, 2025 and for the six months then ended
99.3	Press Release dated October 1, 2025

In addition, effective September 30, 2025, Professor Eli Hazum resigned from the Company’s Board of Directors due to personal reasons. Professor Hazum’s resignation was not the result of any disagreement with the Company or its management. In his place, Asaf Shavit was appointed to serve as a member of the Board of Directors, effective immediately.

Mr. Shavit has more than 35 years of experience providing audit, tax and financial advisory services to public and private companies, including public corporations and subsidiaries of foreign entities. His areas of expertise include audits of financial statements, budget planning and control, taxation, mergers and acquisitions, corporate liquidations, valuations, and complex cross-border and capital markets transactions. He currently serves as Managing Partner at Moalem-Shavit & Co., Certified Public Accountants, since 1995, where he leads a team of more than 14 professionals. Mr. Shavit holds a B.A. in Accounting, Economics and Business Management and an M.B.A. in Business Management with a concentration in Finance and Banking. He is also a Certified Public Accountant.

Exhibit Index

Exhibit No.		Description
99.1		Unaudited Condensed Financial Statements as of June 30, 2025
99.2		Operating and Financial Review as of June 30, 2025 and for the six months then ended
99.3		Press Release dated October 1, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 1, 2025	PAINREFORM LTD.
	By:	/s/ Ehud Geller
		Ehud Geller
		Executive Chairman of the Board and Interim Chief Executive Officer

FAQ

What did PainReform (PRFX) disclose in the October 1, 2025 Form 6-K?

The company announced publication of a press release and attached unaudited condensed financial statements plus an operating and financial review for the six months ended June 30, 2025.

Who left the PainReform board and why?

Professor Eli Hazum resigned effective September 30, 2025 for personal reasons; the filing states his resignation was not due to any disagreement with the company or management.

Who was appointed to the PainReform board following the resignation?

Asaf Shavit was appointed effective immediately; he has over 35 years of experience in audit, tax and financial advisory and is a Certified Public Accountant.

Are the financial statements in the filing audited?

No. The filing attaches unaudited condensed financial statements as of June 30, 2025 for the six-month period.

Does the filing state any disagreement between the departing director and management?

The filing explicitly states Professor Hazum’s resignation was not the result of any disagreement with the company or its management.